SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMNR - Immune Response

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mark B. Martell, CCM who wrote (47)4/19/1997 12:13:00 AM
From: Druss   of 1510
 
Mark, I tend to agree with you that IMNR should have more action.
Particularly in price, my feeling is that the early, hyped up action of this stock has soured investors to it. The price seems low to me for a biotech stock that is obviously serious and having sucess.
However I view this as my speculative long shot. I like its chances for a good run up if they hit a good product.
I think we will have to be patient, I did get in pretty cheap so patience comes easier.
All the Best
Druss
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext